Three insights:
1. Talomon Capital likely amassed its entire stake in Surgery Partners in recent weeks.
2. Talomon Capital manages about $307 million for clients, meaning its investment in Surgery Partners accounts for about 5 percent of its total investments.
3. The value of Surgery Partners’ shares has dropped two-thirds in the past year. Several top executives have left the company, which is working to close a federal investigation into its drug-testing practices.
More articles on transactions and valuation:
Connecticut hospital weighs investing in surgery center — 5 insights
Physicians Endoscopy names new CEO & more — 9 ASC industry notes
California HCA ASC real estate listed for sale at $7M
